by Carl Dumont, Ashish Kaura, and
Sundar Subramanian
Regulatory reform and IT advances are accelerating the “clockspeed” in healthcare. To compete, insurers will need to focus on three key areas.
by Alex Kandybin and Vessela Genova
The business model that drove the major drugmakers’ success isn’t working anymore, and their very future is in doubt. The survivors will be those that make smart strategic bets supported by winning capabilities.
by Marcus Ehrhardt, Robert Hutchens, and
Susan Higgins
Global drug companies are facing their greatest disruption in decades. Today’s remedy may come, not from the labs, but rather from pharma’s manufacturing and operations footprint.
by Joyjit Saha Choudhury, Akshay Kapur, and
Sanjay B. Saxena
As nations seek to expand services more cost-effectively, the stakeholders who pay the bills and provide the care must collaborate.